Assessment of Hyperphosphorylated Tau PET Binding in Primary Progressive Aphasia and Frontotemporal Dementia
Public ClinicalTrials.gov record NCT02736695. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Assessment of Hyperphosphorylated Tau PET Binding in Primary Progressive Aphasia and FTD
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is designed to learn more about overall tau burden in the brain of patients with Primary Progressive Aphasia (PPA) and Frontotemporal Dementia.
Study identification
- NCT ID
- NCT02736695
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 81 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2016
- Primary completion
- Jul 31, 2024
- Completion
- Jul 31, 2024
- Last update posted
- Nov 20, 2025
2016 – 2024
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Primary Progressive Aphasia trials
Other public records listing Primary Progressive Aphasia. Sorted by last update posted; newest first. Not a recommendation.
- NCT07650188: Stimulating the Aging Brain Using Brain and Sensory Stimulation Recruiting
- NCT06191198: Communication Bridge 3 Study Recruiting
- NCT05368350: Treating Primary Progressive Aphasia and Apraxia of Speech Using Non-invasive Brain Stimulation Active, not recruiting
- NCT05386394: Transcranial Direct Current Stimulation in the Treatment of Primary Progressive Aphasia Recruiting
- NCT03313011: The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech Recruiting
- NCT00537004: Language in Primary Progressive Aphasia Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02736695, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 20, 2025 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02736695 live on ClinicalTrials.gov.